Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT)

• Research type

  Research Study

• Full title

  The role of anti-IgE (omalizumab) in the management of severe recalcitrant paediatric atopic eczema

• IRAS ID

  48144

• Contact name

  Susan Chan

• Contact email

  susan.chan@kcl.ac.uk

• Sponsor organisation

  Guy's & St. Thomas' Foundation NHS Trust

• Eudract number

  2010-020841-29

• ISRCTN Number

  xx

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - Westminster Research Ethics Committee

• REC reference

  11/LO/0123

• Date of REC Opinion

  7 Jul 2011

• REC opinion

  Further Information Favourable Opinion